Division of General Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota.
Division of General Thoracic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota.
Ann Thorac Surg. 2018 Apr;105(4):1038-1043. doi: 10.1016/j.athoracsur.2017.10.042. Epub 2018 Feb 15.
Persistent air leak can complicate pulmonary resection, and one management option is dismissal with a chest tube in place. This study evaluated the rate of empyema and readmission after dismissal with a chest tube.
A retrospective review of our prospective database from January 2004 to December 2013 identified 236 patients who were discharged from our institution with an indwelling chest tube and attached one-way valve for air leak. Empyema was defined by leukocytosis or fever and undrained effusion on chest roentgenogram or computed tomography. Readmission was defined as readmission for any reason. Logistic regression analyses were performed to identify risk factors for empyema or readmission.
Median age was 67 years (range, 18 to 91 years). Median chest tube duration was 18 days (range, 6 to 90 days). Empyema occurred in 40 patients (16.9%), and 62 patients (26.3%) were readmitted. Treatment required included antibiotics alone in 45% (18 of 40), further drainage in 30% (12 of 40), fibrinolytic therapy in 12.5% (5 of 40), and operative decortication in 12.5% (5 of 40). Predictors of empyema included male sex, coronary artery disease, and peripheral vascular disease. A secondary analysis grouping patients into an earlier era (2004 to 2008) vs a later era (2009 to 2013) revealed that the use of thoracoscopy increased from 34% to 48% of lung resections and dismissal with a chest tube increased from 3.4% to 4.5% (p = 0.03).
Dismissal with an indwelling chest tube is not without consequence, having significant risk for further complications and potential need for additional interventions.
持续性气胸会使肺切除术复杂化,一种处理选择是带管出院。本研究评估了带管出院后脓胸和再入院的发生率。
回顾性分析 2004 年 1 月至 2013 年 12 月我院前瞻性数据库中 236 例因持续性气胸带管出院的患者。脓胸的定义为白细胞增多或发热,胸部 X 线或 CT 显示未引流的胸腔积液。再入院的定义为任何原因的再入院。采用 logistic 回归分析确定脓胸或再入院的危险因素。
中位年龄为 67 岁(范围 18 至 91 岁)。中位胸腔引流管留置时间为 18 天(范围 6 至 90 天)。40 例(16.9%)发生脓胸,62 例(26.3%)再入院。治疗包括单独使用抗生素(45%,18/40)、进一步引流(30%,12/40)、纤维蛋白溶解治疗(12.5%,5/40)和手术清创(12.5%,5/40)。脓胸的预测因素包括男性、冠心病和外周血管疾病。将患者分为早期(2004 年至 2008 年)和晚期(2009 年至 2013 年)两组的二次分析显示,胸腔镜使用率从 34%增加到 48%,带管出院率从 3.4%增加到 4.5%(p=0.03)。
带管出院并非没有后果,会显著增加进一步并发症的风险和潜在需要额外干预的风险。